Coronavirus: “Fighting will Basically end at the end of April”
The new crown pneumonia epidemic in China has gradually eased, and the “final development” of the new crown virus has attracted much attention from all sides. In response, Zhang Wenhong, the leader of the Shanghai New Crown Pneumonia Medical Treatment Expert Team, said that he believes that the fighting will basically end at the end of April. “You believe that my prediction must be correct.” In addition, he also pointed out recently, “If work is not resumed as soon as possible, The secondary effects of urban stagnation may lead to a higher mortality rate than new coronary pneumonia. ”
. Some people think that the new crown pneumonia virus is “very demon”. However, Zhang Wenhong recently pointed out in an interview with “China News Agency” that after clearing his temper, you will not think that this is a “very demon” virus. “Everyone thinks that the new crown pneumonia is terrible because it is not harmful to the new virus. understanding.”
Since the outbreak of the new crown pneumonia, Zhang Wenhong has been exploring the temper of the virus. He said that this is actually a virus of the coronavirus family, except that his temper is slightly different from other coronaviruses. Symptoms of new coronary pneumonia are a bit like SARS, but they are not as heavy, and spread like flu. The characteristics are a bit between SARS and flu, and they are very “personalized coronaviruses.”
WHO Director-General | Four differences between Newcomer and influenza viruses are important
By WHO Director-General at a media briefing on the coronavirus disease (COVID-19) outbreak on March 3, 2020
Good afternoon everyone, thank you again for participating in person or online.
today is my birthday. I received a great gift from the Democratic Republic of the Congo on our African continent. We have not received a report of an Ebola case for two weeks, and no patients are currently being treated.
This is not only good news for me, but also for the entire world, and especially for the thousands of medical workers who have made great contributions and made brilliant achievements in the fight against Ebola Message. The world was extremely worried about the Ebola virus.
But as one epidemic is about to end, fighting on one front is about to end, and another is becoming increasingly complex.
A total of 90,893 COVID-19 cases and 3,110 deaths have been reported worldwide.
In the past 24 hours, China has reported 129 cases, the lowest number since January 20.
Outside China, 1848 cases were reported in 48 countries. 80% of the cases were from three countries: the Republic of Korea, the Islamic Republic of Iran and Italy.
The first cases were reported in 12 more countries. A total of 21 cases are now reported in 21 countries.
No cases were reported in 122 countries.
The actions taken by these newly affected countries today are significant, and what they do will determine whether there will be a small number or a large number of cases in the future.
We can understand people’s concerns and fears. Fear is the natural response of humans to any threat, especially when it is a threat that we do not fully understand.
But as we get more data, we become more aware of the virus and the diseases it causes.
This virus is not a severe acute respiratory syndrome (SARS) virus, not a Middle East respiratory syndrome (MERS) virus, not an influenza virus. It is a unique virus with unique characteristics.
Both COVID-19 and influenza can cause respiratory diseases and spread in the same way through droplets discharged from the patient’s nose and mouth.
However, there are some significant differences between COVID-19 and influenza.
First, from the data we currently have, COVID-19 is not as efficient as influenza.
In the case of influenza, infected people who have not yet become the main driver of transmission, but COVID-19 does not seem to be the case.
Evidence from China shows that only 1% of reported cases are asymptomatic, and most cases show symptoms within 2 days.
Some countries are using influenza and other respiratory disease surveillance systems to find cases of COVID-19.
China, Ghana, Singapore and other countries have found few or no cases of COVID-19 in such samples.
The only reliable method is to find COVID-19 antibodies in a large number of people, and some countries are currently conducting such research. This will give us a better understanding of the extent of infection in the population over time.
WHO has established procedures for how to conduct such research. We encourage countries to conduct such research and share their data.
The second major difference is that COVID-19 causes more serious illness than seasonal flu.
Many people around the world already have immunity to seasonal influenza strains, but COVID-19 is a new virus and no one is immune to it. This means that more people are susceptible to infection, and some people have serious illnesses.
Globally, approximately 3.4% of COVID-19 reported cases have died. In contrast, deaths from infections caused by seasonal flu are usually well below 1%.
Third, we have vaccines and treatments for seasonal influenza, but there is currently no vaccine and specific treatment for COVID-19. Clinical trials of therapeutic tools are currently underway and more than 20 vaccines are being developed.
Fourth, we don’t even talk about curbing seasonal flu, because this is not possible. But containment of COVID-19 is possible. We do not track seasonal flu contacts, but countries should track COVID-19 contacts as this will prevent infection and save lives. Containment is possible.
In short, the transmission efficiency of COVID-19 is lower than that of influenza. Transmission does not seem to be driven by people who are not sick. It causes more serious diseases than influenza. At present, there is no vaccine or treatment tool, but it can be controlled. Therefore, we must do everything in our power to control it. WHO recommends a comprehensive response to this end.
The above differences mean that we cannot treat COVID-19 as we do flu.
But the two are sufficiently similar that countries do not start from scratch. For decades, many countries have invested in influenza detection and response systems.
Because the COVID-19 virus is also a respiratory pathogen, these detection and response systems can, should, and are being adjusted to respond to COVID-19.
But what worries us is that the global supply of personal protective equipment has been severely and increasingly disrupted due to the surge in demand and the accumulation and abuse, which has affected the country’s ability to respond.
Due to limited access to supplies such as gloves, medical masks, breathing masks, goggles, face shields, protective clothing, and apron, the shortage of supplies has made doctors, nurses, and other front-line health workers inadequately equipped to provide medical services for COVID-19 patients. Dangerous situation.
We cannot stop COVID-19 without protecting medical workers.
The price of surgical masks has increased five-fold, the price of N95 masks has more than tripled, and the price of protective clothing has doubled.
It can take months to deliver, market speculation is common, and inventory is usually sold to the highest bidder.
WHO has shipped nearly 500,000 sets of personal protective equipment to 27 countries, but supplies are rapidly depleting.
WHO estimates that in order to respond to COVID-19, 89 million medical masks, 76 million pairs of medical examination gloves and 1.6 million pairs of goggles will be needed each month.
WHO has guidelines on the proper use of personal protective equipment in health facilities and the effective management of supply chains.
We also work with governments, manufacturers and pandemic supply chain networks to help increase production and secure the supply of personal protective equipment to countries that are severely affected and at risk.
Globally, it is estimated that the supply of personal protective equipment needs to increase by 40%.
We continue to call on manufacturers to urgently increase production to meet this demand and secure supply.
We call on the government to develop incentives to encourage manufacturers to expand production. This includes relaxing restrictions on the export and distribution of personal protective equipment and other medical supplies.
In the final analysis, this is still a matter of solidarity and mutual assistance. This cannot be solved by WHO or by an industry alone. This requires us all to work together to ensure that all countries can protect the health workers who protect us.
thank you all.
Coronavirus: "Fighting will Basically end at the end of April - /10
The new crown pneumonia epidemic in China has gradually eased, and the "final development" of the new crown virus has attracted much attention from all sides.